Thymus transplantation in complete DiGeorge anomaly.

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Complete DiGeorge anomaly presents with athymia, congenital heart disease, and hypoparathyroidism, often fatal by age two without immune reconstitution.
• Associated syndromes include 22q11 hemizygosity (50%), CHARGE association (25%), and diabetic embryopathy (15%).
• A subset of patients exhibits rash and lymphadenopathy due to oligoclonal T cells, mimicking Omenn syndrome, necessitating immunosuppression.

Purpose of the Study:

• To evaluate the efficacy of thymus transplantation for immune reconstitution in patients with complete DiGeorge anomaly.
• To assess survival rates and T cell repertoire diversity post-transplantation.

Main Methods:

• A cohort of 50 patients with complete DiGeorge anomaly underwent thymus transplantation.
• Post-transplantation outcomes, including survival and immune cell development, were monitored.

Main Results:

• Thymus transplantation resulted in a survival rate of 72% (36 out of 50 patients).
• Survivors demonstrated the development of naive T cells and a diverse T cell repertoire, indicating successful immune reconstitution.

Conclusions:

• Thymus transplantation is a viable therapeutic strategy for complete DiGeorge anomaly, significantly improving survival rates.
• Successful transplantation leads to restoration of a functional T cell system, crucial for long-term health.